Astellas Gets CLDN.18.2-Targeted ADC From China’s Evopoint

 
• By Joseph Haas
  
ADC
Astellas licenses Evopoint's CLDN18.2-targeted ADC • Source: Shutterstock

More from Deals

More from Therapy Areas